Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors-Reference-Cited by-同舟云学术

Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors

Published:2020-09 Issue:2 Volume:65 Page:371-377
ISSN:1896-1126
Container-title:Advances in Medical Sciences
language:en
Short-container-title:Advances in Medical Sciences

Author:

Puła Bartosz,Długosz-Danecka Monika,Salomon-Perzyński Aleksander,Szymczyk Agnieszka,Subocz Edyta,Budziszewska Bożena Katarzyna,Rybka Justyna,Gil Lidia,Waszczuk-Gajda Anna,Iskierka-Jażdżewska Elżbieta,Zaucha Jan M.,Osowiecki Michał,Piszczek Weronika,Steckiewicz Paweł,Szukalski Łukasz,Hus Marek,Lech-Marańda Ewa,Jurczak Wojciech,Jamroziak Krzysztof

Funder

National Science Centre in Poland

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. The clinical and epidemiological burden of chronic lymphocytic leukaemia;Redaelli;Eur J Canc Care,2004

2. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Eichhorst;Ann Oncol,2015

3. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia;Landau;Cell,2013

4. Mutations driving CLL and their evolution in progression and relapse;Landau;Nature,2015

5. Genomic aberrations and survival in chronic lymphocytic leukemia;Dohner;N Engl J Med,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib;European Journal of Haematology;2020-12-19

2. Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia;European Journal of Clinical Investigation;2020-10-22